A thorough understanding of the pathogenesis of human immunodeficiency virus (HIV) infection requires a comprehensive knowledge of both the cellular and viral determinants of cell-type-specific viral tropism. During the course of infection, HIV binds to and/or infects a number of different cell types. The major tropic determinant, the interaction between the viral envelope and its receptor, the CD4 antigen on the host cell surface, was appreciated at an early stage in the AIDS epidemic (6, 17, 24) . CD4+ cells, however, represent a broad class, including cells of both the T and monocyte/macrophage lineages, each of which has multiple subclasses. Although studies on differential tropism within the class of CD4+ cells have mostly emphasized the role of viral envelope determinants (3, 14, 22, 25, 31, 32, 36, 37) , any viral gene that interacts directly or indirectly with host cell components can make differential contributions to cell-typespecific viral tropism if the cellular components are cell type specific.
The contributions of the non-envelope genes to tropism are beginning to be appreciated. Replication of HIV vif mutants, for instance, varies greatly according to the cells used for infection (11, 30, 33, 34) . In the simian immunodeficiency virus system, Nef impairs replication in tissue culture but promotes replication in vivo, although these in vivo results do not distinguish cell type tropism from other selective pressures (16) . Although the long terminal repeat is not the major determinant of HIV tropism (28) , evidence suggests that it makes a contribution.
Mutant viruses with all of their Spl sites deleted have differentially impaired replicative capacities in human T-cell lines and peripheral blood lymphocytes (PBLs) (26, 29) . This suggests a differential dependence on SP1 in different cell types. Furthermore, NFKB regulation of the HIV promoter (for a review, see reference 2) suggests differential regula-tion (and presumably differential replication) in cell types in which NFKB is differentially regulated. Of the two major viral regulatory axes (Tat and Rev), only the Tat axis has been definitively implicated in contributing to cell-type-specific viral tropism (4), although the effects reported were small. There is suggestive evidence that Rev operates through different mechanisms in lymphoid and FIG. 1. Sequence and structure of the RRE (9, 10, 20, 21) 
MATERIALS AND METHODS
Construction of proviral HXB2 derivatives with mutated RREs. Mutants RRE3 and RRE4 were reported previously as HXB7415A-7418T and HXB7418T, respectively (9) . The other proviral mutants were constructed as described previously (9 were infected similarly except that they were infected and plated in medium containing 50 U of interleukin-2 (Pharmacia) per ml. All cultures were done in triplicate, and the results were averaged. Reverse transcriptase was assayed as described by Poli et al. (27) .
Computer analysis of RRE sequences in the HIV data base. A set of 41 RRE sequences from different HIV-1 strains were analyzed. The major source of these sequences was the human retrovirus and AIDS nucleic acid data base. The nucleotide sequences of the RREs in the set were compared. The sequences were then grouped by pairwise similarities (18) . The six natural strains discussed in this work (NL4.3, Cdc42, SC, SF33, Eli, and Z321) represent candidates from distinct clusters of the entire set analyzed. The nucleotide variations in each of the strains compared with the sequence of strain HXB2 were evaluated in terms of their disruptive effect on the RRE (Fig. 1) . Only nucleotide variations that caused at least a local helical disruption are presented. Not presented are nucleotide variations in loop regions, at the ends of helices, or exchanges of Watson-Crick and G-U base pairs; all of these leave intact a stable helix. The potential effects of the variations on RRE structure were verified by minimization of free-energy folding (38) , including an evaluation of suboptimal structures (data not shown). Fig. 2A) but severely impair replication in SupTl cells when the virions have been made in COS cells (Fig. 2B) . Making virions in A3.01 cells did not improve the impaired replication of RRE3 and RRE4 in SupTl cells (RRE5 and RRE8 grown in A3.01 were not tested) (Fig. 2C ). RRE3 and RRE4 were also severely impaired for replication in Jurkat cells, regardless of whether they were introduced by virion infection (Fig. 2D ) or direct transfection (Fig. 2E ). Only at later time points does virion production (reverse transcriptase activity) by these mutants in SupTl cells rise to substantial levels (data not shown).
Mutations RRE2, RRE6, and RRE7 (stems I, IV, and V, respectively) minimally impair HIV replication in A3.01 cells or have no effect (Fig. 2F ) but moderately delay replication and minimally decrease peak reverse transcriptase levels in SupTl cells (Fig. 2G) . Mutations RRE7 and RRE8 moderately impair replication in Jurkat cells ( fig. 2D ). Mutations RRE1, RRE9, and RRE10 (stems I, VI and I', respectively) minimally to moderately impair HIV replication in A3.01 cells (Fig. 2H) . However, they all moderately impair replication and significantly decrease peak reverse transcriptase levels in SupTl cells (Fig. 2I) . mary phytohemagglutinin-stimulated PBLs. Mutations RRE3, RRE4, RRE5, and RRE9 cause a moderate reduction in peak reverse transcriptase levels produced by HIV infection of PBLs when the virions were made in COS cells (Fig. 3A) . Mutation RRE8 causes a somewhat greater reduction in peak reverse transcriptase levels than the other mutations. Using virions made in A3.01 resulted in essentially the same minimal to moderate impairment of replication of RRE3 and RRE4 in PBLs (Fig. 3B) . Interestingly, all of these mutants reached peak reverse transcriptase production at the same time as the wild type.
Different observed replication rates of RRE mutants not explained by reversion. The replication kinetics (relative to the wild type) displayed by mutants RRE3 and RRE4 after infection of A3.01 cells are identical to their replication kinetics after transfection ( Fig. 2A ) (see reference 9 for the transfection of A3.01 cells by these mutants). Regardless of whether these mutants were transfected directly or first made in COS cells, their replication rates were almost always impaired (sometimes drastically, sometimes minimally; see above) when they were inoculated onto test cultures. This implies that the viruses that do grow after transfection in A3.01 cells have not significantly reverted or adapted. Thus, the replication kinetics posttransfection and, by implication, the replication kinetics postinfection in A3.01 cells are not influenced by reversion.
The replication of mutants RRE3 and RRE4 in SupTl cells was somewhat different. In this situation, reverse transcriptase activity begins to appear in the supernatant approximately 18 days postinfection and rises to high levels (data not shown). When virions are harvested from these cultures, however, they grow with rapid kinetics on SupTl cells (Fig.  4) . This suggests that the eventual replication of these mutants in SupTl cells derives from reversion or adaptation. The impairment of replication in SupTl cells caused by these mutations, as indicated in Fig. 2B , is at most an underestimate of the true impairment.
Replication of mutants RRE3, RRE4, and RRE5 is severely impaired in SupTl cells. To rule out the possibility that mutant viruses might be replicating and spreading throughout the SupTl cultures without virion release, we harvested RNA from SupTl cultures at 10 days postinfection. Northern (RNA blot) analysis clearly shows that whereas wildtype HXB2-infected cultures contain large amounts of viral RNA, cultures infected by mutant RRE3, RRE4, or RRE5 do not contain detectable viral RNA (Fig. 5) . Thus, there is no detectable spreading infection masked by a failure to release virions. (13) . Many entries in the HIV data base have apparent disruptions in the GCG in the 5' side of stem lIc, but these have not been listed because of common sequencing errors in this region as a result of GC compression (7). Cdc42 is listed, however, with an A replacing the first G of this sequence because the GC compression is unlikely to be misread as an A. Cdc42 also has a disruption at the base of stem V. RRE mutation impairs HIV replication differently in a variety of cultured cell lines. Figure 6 summarizes the effects of RRE mutations on viral replication in several lymphocytic and monocytic cell types. In general, mutation of the RRE almost always has at least slightly inhibitory effects on the time of peak reverse transcriptase levels and/or on the magnitude of peak reverse transcriptase levels ( Fig. 6 and data not shown). The spectrum of inhibitory effects seen in the lymphocytic cells (A3.01, SupTl, Jurkat, PBL, MT4, and H9) does not characteristically differ from the spectrum of inhibitory effects seen in the monocytic cells (U937 and THP1; Fig. 2 and 6 ).
Natural isolates of HIV often have impaired RRE structures. Because all of the RRE mutations reported here have at least a slight impairment of replication in all the cell types tested, we asked whether defective RREs are ever selected by growth in a natural environment. A search of the HIV data base (see Materials and Methods) yielded several RRE sequences with disruptions in the established RRE structural model. Strains with disruptions in the primary Rev-binding domain included Eli, SC, Cdc42, RF, SF33, and pNL4.3. Strain Cdc42 also has a disruption at the base of stem V, outside of the primary Rev-binding domain (Fig. 7) (19, 20) . These disruptions may be associated with other viral genomic roles, such as coding for altered envelope proteins which confer a selective advantage on viral replication. Alternatively, these disruptions may be associated with a selective advantage for the viral host cells rather than for maximal viral replication rates in a particular cell type.
Theoretically, there should be many viral contributors to cell-type-specific tropism. As HIV replicates within the many different cell types which it can infect in vivo, it may not have time to completely discard all of the tropic determinants which are deleterious for growth in any single cell type. Natural isolates may represent a mosaic of determinants as well as of determinant types. Any consideration of tropism must therefore consider all of the contributors to tropism. Furthermore, consideration of cell-type-specific tropism necessarily implies relative tropism, i.e., relative growth rates in one cell type versus some other. Although RRE defects may have only minimally impairing effects in one cell type, such as the cell type favored for viral replication, they may have severely debilitating effects on replication in another cell type for which replication has not been selected. The contribution of the RRE to cell-type-specific tropism may be more notable for its lack of deleterious effects than for the contribution of positive effects. Although it is unlikely that the contribution of the RRE to any given tropism is unique, from the data presented here, it is clear that its contribution can be major.
RRE probably contributes to tropic effects in vivo. The cell types studied here include representatives of monocytic and lymphocytic lineages. With the exception of primary human PBLs, it remains unclear to which in vivo cellular pools these cell types correspond. Nevertheless, the frequent occurrence of natural isolates bearing disruptions of the RRE strongly suggests that the RRE may have significant tropic effects in a natural setting. Future considerations of tropic determinants must therefore consider possible contributions from the RRE.
It does not appear that any RRE mutations have characteristically different effects in monocytes than in T cells. On the contrary, the most dramatic differences are seen among different members of the T-cell set. It remains unclear what cellular characteristics mediate these effects and to which in vivo cellular pools these cell types correspond.
Implication for cellular factors involved in the Rev axis of HIV autoregulation. Many of the RRE mutations presented here are outside of the Rev-binding domain of the RRE, in a region that we have recently proposed to be involved in the binding of cellular factors required for maximal efficiency of the Rev axis (9) . The finding that mutations in this area can result in changes in cell-type-specific viral tropism is consistent with this proposal. Also consistent with this proposal is the finding that the stems inside this region are actually better conserved than are the stems of the primary Revbinding domain. Although many of the effects reported here may derive from cell-type-specific cellular factors interacting with the RRE, we cannot rule out that these effects are due solely to secondary Rev-binding events outside of the primary Rev-binding domain. On the contrary, preliminary experiments suggest no lack of correlation between the binding of the RRE mutants to Rev protein in vitro and their replication rates ex vivo (data not shown). Nor can we rule out that the differences are due to different efficiencies of cis repressor sequences in the different cell types or to some mechanistic differences downstream of the Rev mechanism. Experiments are now being conducted to address these possibilities.
